Author: Mazalovska, Milena; Kouokam, J. Calvin
Title: Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections Document date: 2018_5_8
ID: 0spmy8vn_33
Snippet: Coronaviruses constitute an important class of human and animal pathogens, and some have been assessed for their susceptibility to lectins. Interestingly, GRFT also prevents SARS coronavirus (SARS-CoV) infection in vitro and in vivo, through specific binding to its spike glycoprotein, and shows activity against multiple other coronaviruses pathogenic to humans, other mammals, and birds; in mice, these inhibitory effects were accompanied with a sp.....
Document: Coronaviruses constitute an important class of human and animal pathogens, and some have been assessed for their susceptibility to lectins. Interestingly, GRFT also prevents SARS coronavirus (SARS-CoV) infection in vitro and in vivo, through specific binding to its spike glycoprotein, and shows activity against multiple other coronaviruses pathogenic to humans, other mammals, and birds; in mice, these inhibitory effects were accompanied with a specific inhibition of deleterious host immune reactions in response to SARS [85] . The Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic human coronavirus, is inhibited at the entry level by GRFT to prevent infection in vitro [86] . In addition, Hippeastrum hybrid agglutinin (HHA), GNA, Cymbidium agglutinin (CA), and Urtica dioica agglutinin (UDA) demonstrate antiviral activities against coronaviruses in vitro and/or in vivo [67] . In an impressive screening of 33 plant lectins, remarkable antiviral effects on both SARS-CoV and feline infectious peritonitis virus (FIPV) with EC50 values at low g/ml levels were observed, with strongest activities found predominantly among mannosebinding lectins [66] . Based on these data, lectins should be included in antiviral strategies to fight SARS coronavirus infections [87] .
Search related documents:
Co phrase search for related documents- animal human and antiviral effect: 1, 2, 3, 4, 5, 6, 7
- animal human and antiviral strategy: 1
- animal human and Cymbidium agglutinin: 1
- animal human and entry level: 1
- animal human and feline FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6
- animal human and FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6
- animal human and GNA Hippeastrum HHA hybrid agglutinin: 1
- animal human and HHA hybrid agglutinin: 1
- animal human and highly pathogenic human coronavirus: 1, 2
- animal human and Hippeastrum HHA hybrid agglutinin: 1
- animal human and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- animal human and hybrid agglutinin: 1
- animal human and important class: 1
- animal human and infectious peritonitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- animal human and inhibitory effect: 1, 2, 3, 4, 5, 6
- animal human and peritonitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- animal human and SARS coronavirus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- animal human and SARS CoV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- animal human and SARS response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Co phrase search for related documents, hyperlinks ordered by date